APC Research Journal | Science Spotlight
When we talk about cellular energy, mitochondria usually get the attention. Often called the “powerhouses” of the cell, mitochondria help convert nutrients into adenosine triphosphate, or ATP—the chemical energy used throughout cellular biology.
But an interesting area of mitochondrial research goes deeper than simply asking how much energy mitochondria produce.
Researchers are also investigating the structures that allow mitochondria to produce that energy efficiently.
That brings us to SS-31, also known in scientific literature as elamipretide, and an unusual mitochondrial phospholipid called cardiolipin.
What Makes Cardiolipin Interesting?
Cardiolipin is concentrated in the inner mitochondrial membrane, where it contributes to both mitochondrial structure and function.
That membrane isn't smooth. It folds inward to form structures called cristae. These folds provide an organized environment for components of the electron transport chain and oxidative phosphorylation—the machinery involved in ATP production.
Cardiolipin helps support cristae architecture and interacts with proteins involved in mitochondrial respiration.
In other words, cardiolipin isn't simply another component of the membrane. It is part of the structural environment in which mitochondrial energy production occurs.
Where Does SS-31 Enter the Picture?
SS-31 is a small, mitochondria-targeting tetrapeptide that has been extensively investigated for its interaction with the inner mitochondrial membrane.
A major focus of that research is its association with cardiolipin.
Earlier descriptions of SS-31 often emphasized its potential effects on reactive oxygen species and oxidative stress. More recent research has expanded that picture considerably.
Studies have examined how the interaction between SS-31 and cardiolipin may influence membrane electrostatics, cardiolipin-dependent proteins, cristae organization, electron transport and overall mitochondrial bioenergetics.
That distinction is important.
SS-31 research isn't simply about “adding energy.”
It's about studying the machinery responsible for producing it.
Why Mitochondrial Structure Matters
Biology frequently reminds us that structure and function are connected.
Within mitochondria, the organization of the inner membrane helps create the environment necessary for oxidative phosphorylation. Cardiolipin contributes to that organization and is associated with several proteins and protein complexes involved in mitochondrial function.
This has made the SS-31/cardiolipin interaction an intriguing research target.
Rather than approaching mitochondria simply as tiny cellular batteries, researchers can investigate how membrane composition, architecture, protein organization and bioenergetics interact with one another.
An Evolving Research Story
SS-31 has been investigated in numerous preclinical models, and elamipretide has also progressed into clinical research. However, experimental findings, proposed mechanisms and clinical outcomes should not be treated as interchangeable.
The precise molecular consequences of SS-31's interaction with mitochondrial membranes continue to be investigated.
That's part of what makes mitochondrial science so interesting.
As researchers learn more about cardiolipin, membrane organization and mitochondrial bioenergetics, our understanding of SS-31 has evolved beyond its earlier description as simply a compound associated with oxidative stress.
It has become part of a much larger scientific question:
How does the organization of the mitochondrial inner membrane influence the way cells produce and manage energy?
And that question takes us directly to another fascinating mitochondrial research peptide—MOTS-c—which approaches mitochondrial biology from a very different direction.
We'll explore that next.
Curiosity Driven. Science Focused. Community Built.
Research Notice
This article is provided for educational and research discussion only. Arizona Peptide Collective products are intended strictly for laboratory research use only and are not for human consumption. Nothing in this article constitutes medical advice, diagnosis, treatment guidance, or a recommendation for human use.
Selected Scientific Reading
Sabbah HN, et al. Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. Biomedicine & Pharmacotherapy. 2025.
Mitchell W, et al. The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. Journal of Biological Chemistry. 2020.
Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. 2014.
